{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260623748526/en/DiaMedica-Therapeutics-Announces-First-Patients-Dosed-in-Phase-2-Trial-of-DM199-for-the-Treatment-of-Fetal-Growth-Restriction", "message": "News view counter 811628 successfully enlarged"}